Encompass Health Co. (NYSE:EHC) Given Consensus Rating of “Buy” by Analysts

Shares of Encompass Health Co. (NYSE:EHCGet Free Report) have been assigned an average recommendation of “Buy” from the eight analysts that are presently covering the firm, MarketBeat.com reports. Seven research analysts have rated the stock with a buy recommendation and one has given a strong buy recommendation to the company. The average 12 month price objective among brokerages that have issued ratings on the stock in the last year is $83.22.

EHC has been the subject of several research analyst reports. Truist Financial increased their price objective on Encompass Health from $82.00 to $86.00 and gave the stock a “buy” rating in a report on Friday, February 9th. Royal Bank of Canada reissued an “outperform” rating and set a $83.00 price objective on shares of Encompass Health in a research report on Friday, February 9th. Barclays lifted their target price on shares of Encompass Health from $95.00 to $101.00 and gave the company an “overweight” rating in a research note on Thursday. Mizuho increased their price target on shares of Encompass Health from $77.00 to $82.00 and gave the stock a “buy” rating in a research note on Friday, February 9th. Finally, Stephens reaffirmed an “overweight” rating and set a $85.00 price objective on shares of Encompass Health in a research report on Tuesday, January 16th.

View Our Latest Research Report on Encompass Health

Encompass Health Trading Up 6.5 %

Shares of EHC stock opened at $82.58 on Friday. The company has a debt-to-equity ratio of 1.19, a current ratio of 1.28 and a quick ratio of 1.28. Encompass Health has a 1-year low of $52.56 and a 1-year high of $83.73. The business has a 50-day moving average of $74.58 and a 200 day moving average of $68.99. The stock has a market capitalization of $8.27 billion, a PE ratio of 23.80, a P/E/G ratio of 1.53 and a beta of 0.93.

Encompass Health (NYSE:EHCGet Free Report) last issued its earnings results on Wednesday, February 7th. The company reported $0.95 EPS for the quarter, topping the consensus estimate of $0.83 by $0.12. Encompass Health had a net margin of 7.33% and a return on equity of 17.69%. The company had revenue of $1.25 billion for the quarter, compared to the consensus estimate of $1.24 billion. As a group, sell-side analysts anticipate that Encompass Health will post 3.96 earnings per share for the current year.

Encompass Health Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Monday, April 15th. Stockholders of record on Monday, April 1st will be issued a dividend of $0.15 per share. The ex-dividend date is Thursday, March 28th. This represents a $0.60 annualized dividend and a dividend yield of 0.73%. Encompass Health’s payout ratio is 17.29%.

Institutional Trading of Encompass Health

Several hedge funds and other institutional investors have recently made changes to their positions in EHC. Principal Securities Inc. purchased a new stake in shares of Encompass Health in the fourth quarter worth $25,000. Benjamin F. Edwards & Company Inc. grew its position in Encompass Health by 360.2% during the 4th quarter. Benjamin F. Edwards & Company Inc. now owns 405 shares of the company’s stock valued at $27,000 after purchasing an additional 317 shares during the last quarter. McGlone Suttner Wealth Management Inc. bought a new stake in Encompass Health during the 4th quarter valued at about $30,000. GAMMA Investing LLC bought a new position in shares of Encompass Health in the fourth quarter worth approximately $33,000. Finally, C M Bidwell & Associates Ltd. purchased a new stake in shares of Encompass Health during the third quarter valued at approximately $35,000. Hedge funds and other institutional investors own 97.25% of the company’s stock.

About Encompass Health

(Get Free Report

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.

Featured Articles

Analyst Recommendations for Encompass Health (NYSE:EHC)

Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.